Will you have Diabetic nephropathy with Effexor xr - from FDA reports


Diabetic nephropathy is found among people who take Effexor xr, especially for people who are male, 30-39 old also take medication Seroquel, and have Insomnia. This study is created by eHealthMe based on reports of 27,366 people who have side effects when taking Effexor xr from FDA, and is updated regularly.

What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on venlafaxine hydrochloride (the active ingredients of Effexor xr) and Effexor xr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Diabetic nephropathy are also considered in the study.

What is Effexor xr?

Effexor xr has active ingredients of venlafaxine hydrochloride. It is often used in depression. (latest outcomes from Effexor xr 30,884 users)

What is Diabetic nephropathy?

Diabetic nephropathy (diabetic kidney disease) has been reported by people with high blood pressure, diabetes, type 2 diabetes, depression, high blood cholesterol (latest reports from 2,454 Diabetic nephropathy patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.

On Mar, 14, 2019

27,366 people reported to have side effects when taking Effexor xr.
Among them, 28 people (0.1%) have Diabetic nephropathy

Number of reports submitted per year:

Could Effexor xr cause Diabetic nephropathy?

Gender of people who have Diabetic nephropathy when taking Effexor xr *:

  • female: 46.43 %
  • male: 53.57 %

Age of people who have Diabetic nephropathy when taking Effexor xr *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 37.04 %
  • 40-49: 18.52 %
  • 50-59: 33.33 %
  • 60+: 11.11 %

Top conditions involved for these people *:

  1. Affective Disorder (mental disorder): 9 people, 32.14%
  2. Insomnia (sleeplessness): 9 people, 32.14%
  3. Anger: 8 people, 28.57%
  4. Sleep Disorder: 8 people, 28.57%
  5. Bipolar Disorder (mood disorder): 7 people, 25.00%
  6. Cardiac Disorder: 6 people, 21.43%
  7. Pain: 6 people, 21.43%
  8. High Blood Cholesterol: 3 people, 10.71%
  9. Indigestion: 3 people, 10.71%
  10. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 10.71%

Top co-used drugs for these people *:

  1. Seroquel: 26 people, 92.86%
  2. Neurontin: 15 people, 53.57%
  3. Paxil: 14 people, 50.00%
  4. Remeron: 12 people, 42.86%
  5. Aspirin: 11 people, 39.29%
  6. Xanax: 11 people, 39.29%
  7. Vistaril: 11 people, 39.29%
  8. Risperdal: 11 people, 39.29%
  9. Zyprexa: 9 people, 32.14%
  10. Ativan: 9 people, 32.14%

Top other side effects for these people *:

  1. Type 2 Diabetes: 21 people, 75.00%
  2. Diabetes Mellitus Inadequate Control: 14 people, 50.00%
  3. Diabetes: 11 people, 39.29%
  4. Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 10 people, 35.71%
  5. Neuropathy Peripheral (surface nerve damage): 6 people, 21.43%
  6. Diabetic Complication: 6 people, 21.43%
  7. Type 1 Diabetes: 5 people, 17.86%
  8. Hypoglycemia (low blood sugar): 5 people, 17.86%
  9. High Blood Cholesterol: 5 people, 17.86%
  10. Pressure Ulcer: 4 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you have Diabetic nephropathy while taking Effexor xr?

You are not alone:

Related studies

Drugs that are associated with Diabetic nephropathy
Diabetic nephropathy (848 drugs)
Could your condition cause Diabetic nephropathy
Diabetic nephropathy (366 conditions)
Effexor xr side effects

Browse side effects by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Effexor xr
a b c d e f g h i j k l m n o p q r s t u v w x y z
Compare Effexor xr with similar drugs

What would happen?

Predict new side effects and undetected conditions when you take Effexor xr and have Diabetic nephropathy

FDA reports used in this study

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.